| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3027373 | Thrombosis Research | 2014 | 5 Pages |
Abstract
ABSTRACTThe complement system is important part of our innate immune system and interacts directly with the hemostatic system. Disorders of complement activation or dysregulation resulting in excess complement generation, such as Paroxysmal Nocturnal Hemoglobinuria (PNH), atypical Hemolytic uremic Syndrome (aHUS) and antiphospholipid syndrome (APLS) have been associated with significant thrombophilia. Terminal Complement (C5b–9) deposition on endothelial and tumor cell membranes has also been reported in a variety of cancer. Recent developments in complement inhibition have given us new insights into the mechanism of thrombosis in these disorders.© 2014 Elsevier Ltd. All rights reserved.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
